
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
1 Twin Research and Genetic Epidemiology Unit, King's College London, St. Thomas Hospital Campus; 2 Division of Basic Medical Sciences, St. George's, University of London, Cranmer Terrace, London, United Kingdom; 3 Dermatology Department, West Hertfordshire NHS Trust, Hemel Hempstead General Hospital, Herts, United Kingdom; and 4 Center of Human Development and Aging, University of Medicine and Dentistry of New Jersey, Newark, New Jersey
Requests for reprints: Veronique Bataille, Twin Research and Genetic Epidemiology Unit, King's College London, St. Thomas Hospital Campus, London SE1 7EH, United Kingdom. Phone: 441442287588; Fax: 441442287588. E-mail: bataille{at}doctors.org.uk
Nevus counts represent one of the strongest risk factors for melanoma. They appear in childhood and adolescence and involute from middle age onwards. Recent evidence has shown that nevus cells undergo oncogene-induced senescence involving the p16/retinoblastoma pathway. However, telomere length also influences senescence in proliferative somatic cells and varies between individuals. This study explores whether telomere length measured in white cells is associated with nevus count and size in 1,897 Caucasian women ages 18 to 79 years. Total body nevus counts were positively correlated with white cell telomere length (mean, 7.09 kbp; range, 5.09-9.37) after adjustment for age (P = 0.0001). Age-adjusted telomere length was also associated with nevus count for nevi above 5 mm in diameter (P = 0.04). Subjects in the top category for nevus count had an average age-adjusted telomere length 150 bp longer than those in the lowest category. The positive correlation between white cell telomere length and nevi number and size may reflect an increased replicative potential (reduced senescence) in individuals with longer telomeres, which may not be melanocyte specific. Understanding mechanisms influencing the induction and involution of nevi will not only help in understanding the pathophysiology of melanoma but should also shed light on the complex relationship between aging and cancer. (Cancer Epidemiol Biomarkers Prev 2007;16(7):1499502)
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |